Skip Navigation

JNCI Journal of the National Cancer Institute 2003 95(9):640-641; doi:10.1093/jnci/95.9.640
© 2003 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Kreeger, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kreeger, K.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 95, No. 9, 640-641, May 7, 2003
© 2003 Oxford University Press

NEWS

Consortia, ‘Big Science’ Part of a Paradigm Shift for Genetic Epidemiology

Karen Kreeger

The first 10% of the full text of this article appears below.

The field of cancer genetics and epidemiology is experiencing a revolutionary shift in approach. Researchers are looking at gene–environment relationships in cancer on a larger scale with new technologies and with more laboratories collaborating than ever before.

Investigators have long pondered how to best analyze low penetrance susceptibility genes, and in particular how to look at them in conjunction with a host of nongenetic factors from lifestyle choices such as cigarette smoking to external exposures, said Robert Hoover, M.D., director of the Epidemiology and Biostatistics Program at the National Cancer Institute.

"We’re about there technologically, and we’re going to see very shortly massive undertakings where investigators will be able to look at multiple genes, maybe . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?